AVAH

Healthcare

Aveanna Healthcare Holdings Inc. · Medical - Care Facilities · $2B

UQS Score — Balanced Preset
48.7
Below Average

Aveanna Healthcare Holdings Inc. scores 48.7/100 using the Balanced preset.

UQS vs Healthcare Sector
AVAH
48.7
Sector avg
32.4
Quality
Good
Moat
Weak
Growth
Weak
Risk
Weak
Valuation
Attractive

What is Aveanna Healthcare Holdings Inc.?

Aveanna Healthcare Holdings is a home care platform operating across the United States, focused on keeping medically complex patients — especially children — out of high-cost hospital settings. The company serves patients through skilled nursing, therapy, and nutrition services delivered at home.

Aveanna generates revenue across three business segments: Private Duty Services, Home Health and Hospice, and Medical Solutions. The Private Duty Services segment provides in-home skilled nursing to medically fragile children, school-based nursing, pediatric day healthcare, and therapy services. The Home Health and Hospice segment delivers skilled nursing, physical and occupational therapy, and end-of-life care to adult patients. The Medical Solutions segment supplies enteral nutrition products to patients on a recurring basis.

Aveanna Healthcare was incorporated in 2016 and is headquartered in Atlanta, Georgia.

  • Private duty nursing for medically fragile children
  • Home health and hospice services for adults
  • School-based and clinic-based pediatric therapy
  • Enteral nutrition supply and delivery
  • Employer of record and personal care support

Is AVAH a Good Stock to Buy?

UQS Score rates AVAH as Below Average overall, reflecting meaningful structural challenges across several key pillars.

Among the five pillars, Quality stands out as the relative bright spot, suggesting the business maintains some operational discipline within its care delivery model. Valuation is rated Attractive, meaning the stock may be priced at a discount relative to its fundamentals — a factor worth weighing alongside the broader risk profile.

The Moat, Growth, and Risk pillars all register as Weak, pointing to limited competitive differentiation, constrained expansion prospects, and an elevated risk profile that investors should carefully consider.

See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →

Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.

Does AVAH pay dividends?

No — Aveanna Healthcare Holdings Inc. does not currently pay a dividend.

Aveanna Healthcare does not currently pay a dividend. As a company operating in a capital-intensive home care model while managing a complex cost structure, available cash is directed toward operational needs and debt obligations rather than shareholder distributions. Income-focused investors should factor this into their assessment.

When does AVAH report earnings?

Aveanna Healthcare reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.

The company's quarterly results tend to reflect the dynamics of reimbursement rates, labor costs, and patient volume across its three segments. Shifts in Medicaid policy and staffing availability have been recurring themes in its reporting cycle.

For the most recent quarter's results and guidance, visit Aveanna Healthcare's investor relations page directly.

AVAH Price History

-44.7% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in Aveanna Healthcare Holdings Inc.?

$
Today it would be worth
$14,119
That's a +41.2% total return, or +41.2% annualized.

Based on Aveanna Healthcare Holdings Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

AVAH Long-term Outlook

The UQS Growth pillar for AVAH is rated Weak, indicating that near-term expansion is not a clear strength of the business. The Risk pillar is also Weak, suggesting the company faces headwinds — including reimbursement uncertainty and labor market pressures — that could weigh on forward performance. The Attractive Valuation rating introduces a counterbalancing consideration: if operational conditions stabilize, the current price level may reflect more pessimism than the underlying business warrants.

Growth drivers

  • Expanding demand for home-based care as an alternative to hospital settings
  • Potential reimbursement rate improvements across Medicaid and Medicare programs
  • Cross-segment synergies between nursing, therapy, and nutrition services

Key risks

  • Ongoing labor shortages and wage inflation in home health staffing
  • Reimbursement rate volatility from Medicaid and government payers
  • Elevated debt load limiting financial flexibility

AVAH vs Peers

Aveanna operates in a fragmented home care and healthcare services landscape alongside several publicly traded peers.

ARDTSimilar UQS
Ardent Health Partners, LLC

Ardent focuses on acute care hospital operations, representing a higher-acuity, facility-based model compared to Aveanna's home-centered approach.

ASTHAVAH scores higher
Astrana Health, Inc.

Astrana operates a physician-led, value-based care network, emphasizing outpatient and managed care coordination rather than home nursing services.

HCSGAVAH scores lower
Healthcare Services Group, Inc.

Healthcare Services Group provides housekeeping and dietary services to long-term care facilities, serving a different patient setting than Aveanna's home-based model.

Frequently Asked Questions

What does Aveanna Healthcare do?

Aveanna Healthcare is a home care platform that provides private duty nursing, home health and hospice services, pediatric therapy, and enteral nutrition to patients across the United States. Its model is built around keeping medically complex patients — particularly children — at home rather than in hospitals or institutional care settings.

Does AVAH pay dividends?

No, Aveanna Healthcare does not currently pay a dividend. The company directs its available resources toward operational requirements and managing its debt obligations. Investors seeking regular income distributions should note this when evaluating AVAH.

When does AVAH report earnings?

Aveanna Healthcare follows a standard quarterly earnings reporting schedule. The timing of specific releases can shift, so investors should check the company's investor relations page for the most current schedule and recent filings.

Is AVAH a good stock to buy?

UQS Score rates AVAH as Below Average overall. While the Valuation pillar is Attractive and Quality shows relative strength, the Moat, Growth, and Risk pillars are all rated Weak. The full pillar breakdown — available to Pro members — provides a more complete picture for making an informed decision.

Is AVAH overvalued?

Based on the UQS Valuation pillar, AVAH is rated Attractive, suggesting the stock may be trading at a discount relative to its fundamentals. However, an attractive price alone does not offset the Weak ratings in Growth and Risk. Investors should weigh valuation in context of the full quality profile.

How does AVAH compare to its competitors?

Aveanna competes in a fragmented healthcare services market alongside peers like Ardent Health Partners, Astrana Health, and Healthcare Services Group. Each operates a distinct model — from hospital systems to physician networks to facility services — making direct comparisons nuanced. The UQS platform scores each ticker independently for side-by-side quality comparison.

What is AVAH's market cap bracket?

Aveanna Healthcare is classified as a small-cap company. This places it in a segment of the market that can offer higher growth potential but also tends to carry greater volatility and liquidity risk compared to large- or mega-cap healthcare peers.

Who founded Aveanna Healthcare?

Aveanna Healthcare was formed through the combination of Epic Health Services and PSA Healthcare, backed by Bain Capital. The company was incorporated in 2016 and has grown through acquisitions to become one of the larger home care platforms in the United States. Full founding details are publicly available through the company's filings.

Is AVAH a long-term quality investment?

As a long-term quality indicator, the UQS Score rates AVAH as Below Average. The Weak Moat pillar suggests limited durable competitive advantages, and the Weak Growth pillar points to constrained long-term expansion prospects. The Attractive Valuation may appeal to contrarian investors, but quality durability remains a key concern.

What is the main competitive advantage of Aveanna Healthcare?

Aveanna's primary differentiator is its scale as a diversified home care platform — combining nursing, therapy, and nutrition services under one organization. This allows it to serve complex patient needs across multiple care types. However, the UQS Moat pillar rates this advantage as Weak relative to sector peers, reflecting the competitive and reimbursement-driven nature of home care.

What sector does AVAH belong to?

Aveanna Healthcare operates in the Healthcare sector, specifically within home health and personal care services. It sits at the intersection of pediatric care, adult home health, and medical nutrition — a niche that is closely tied to government reimbursement programs like Medicaid and Medicare.

Unlock Full AVAH Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • View the complete five-pillar UQS Score breakdown
  • Access full financial metrics and trend data
  • Compare AVAH against sector peers by pillar
  • See the detailed Risk and Moat assessments
  • Track score changes over time with Pro alerts
Analyze AVAH in Detail →

Pro Analysis

AVAH — Score History

4045505560Apr 2Apr 12Apr 22May 2May 12May 22May 24v5
Score changes· 30/33 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 23, 202648.574.632.039.18.885.0+0.2
May 22, 202648.374.632.039.08.883.40.0
May 21, 202648.374.632.039.08.883.8-0.1
May 20, 202648.474.632.039.08.884.0+0.2
May 19, 202648.274.632.039.08.882.70.0
May 18, 202648.274.632.039.08.882.6+0.1
May 17, 202648.174.632.038.78.882.3+0.2
May 16, 202647.974.632.038.18.881.7-0.1
May 15, 202648.074.632.037.68.883.5-0.6
May 14, 202648.674.632.037.68.887.7-0.2

AVAH — Pillar Breakdown

Quality

74.6/100 (25%)

Aveanna Healthcare Holdings Inc. shows solid profitability with healthy returns on capital and reasonable margins.

Capital Efficiency (ROIC)Moderate

How effectively capital is deployed to generate returns.

Return on EquityStrong

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityModerate

Bottom-line profit as a share of revenue.

Gross Profit / AssetsStrong

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

39.1/100 (20%)

Aveanna Healthcare Holdings Inc. shows steady but unspectacular growth, typical for mature companies.

Recent Revenue TrendModerate

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthWeak

Analyst consensus for future earnings growth.

Risk

8.8/100 (15%)

Aveanna Healthcare Holdings Inc. presents elevated risk with concerns around leverage or financial stability.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityWeak

Total debt relative to shareholder equity.

Current RatioWeak

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

86.1/100 (15%)

Aveanna Healthcare Holdings Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Earnings YieldStrong

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

EV/EBITDA vs SectorModerate

Enterprise value multiple relative to sector median.

Moat

32/100 (25%)

Aveanna Healthcare Holdings Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for AVAH.

Score Composition

Quality
74.6×25%18.6
Growth
39.1×20%7.8
Risk
8.8×15%1.3
Valuation
86.1×15%12.9
Moat
32.0×25%8.0
Total
48.7Below Average

Financial Data

More Stock Analysis

How is the AVAH UQS Score Calculated?

The UQS (Unified Quality Score) for Aveanna Healthcare Holdings Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Aveanna Healthcare Holdings Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Aveanna Healthcare Holdings Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.